...
首页> 外文期刊>Journal of Infectious Diseases >Reduced Tim-3 Expression on Human T-lymphotropic Virus Type I (HTLV-I) Tax-specific Cytotoxic T Lymphocytes in HTLV-I Infection
【24h】

Reduced Tim-3 Expression on Human T-lymphotropic Virus Type I (HTLV-I) Tax-specific Cytotoxic T Lymphocytes in HTLV-I Infection

机译:减少人类T型淋巴病毒I型(HTLV-I)税收特异性细胞毒性T淋巴细胞中Tim-3表达的HTLV-I感染。

获取原文

摘要

T cell immunoglobulin and mucin domain-containing molecule-3 (Tim-3) and programmed cell death-1 (PD-1) are T cell exhaustion molecules. We investigated the expression of Tim-3 and PD-1 in human T-lymphotropic virus type I (HTLV-I) infection. Tim-3 expression, but not PD-1 expression, was reduced on CD4+ and CD8+ T cells of HTLV-I–associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients and HTLV-I carriers as compared with healthy controls. Tim-3 expression was also reduced in HTLV-I Tax-specific cytotoxic T lymphocytes (CTLs) as compared with cytomegalovirus-specific CTLs. Tim-3+, but not PD-1+, Tax-specific CTLs produced less interferon-γ and exhibited low cytolytic activity. However, we observed no difference in the expression of Tim-3 or cytolytic activity between Tax-specific CTLs of HAM/TSP patients or carriers. Moreover, HTLV-I–infected CD4+ T cells showed decreased Tim-3 expression. These data suggest that Tim-3 expression is reduced in HTLV-I infection and that a high number of Tim-3- HTLV-I–specific CTLs preserves their cytolytic activity, thereby controlling viral replication.
机译:T细胞免疫球蛋白和含粘蛋白结构域的分子3(Tim-3)和程序性细胞死亡1(PD-1)是T细胞衰竭分子。我们调查了人类T型淋巴病毒I型(HTLV-1)感染中Tim-3和PD-1的表达。在HTLV-1相关性脊髓病/热带痉挛性轻瘫(HAM / I)的CD4 + 和CD8 + T细胞上,Tim-3表达降低,而PD-1表达降低。 TSP)患者和HTLV-1携带者与健康对照相比。与巨细胞病毒特异性CTL相比,HTLV-1 Tax特异性细胞毒性T淋巴细胞(CTL)中的Tim-3表达也降低。 Tim-3 + ,而不是PD-1 + ,Tax特异性CTL产生的干扰素-γ较少,且细胞溶解活性较低。但是,我们观察到HAM / TSP患者或携带者的Tax-specific CTL之间Tim-3的表达或细胞溶解活性没有差异。此外,HTLV-1感染的CD4 + T细胞显示Tim-3表达降低。这些数据表明,在HTLV-1感染中Tim-3表达降低,并且大量的Tim-3 - HTLV-1特异性CTL保留了它们的溶细胞活性,从而控制了病毒复制。

著录项

  • 来源
    《Journal of Infectious Diseases 》 |2011年第7期| p.948-959| 共12页
  • 作者单位

    Division of Molecular Pathology, Center for Chronic Viral Diseases;

    Division of Molecular Pathology, Center for Chronic Viral Diseases;

    Department of Neurology and Geriatrics, Graduate School of Medical and Dental Sciences, Kagoshima University, 8-35-1 Sakuragaoka, Kagoshima, Japan;

    Department of Neurology and Geriatrics, Graduate School of Medical and Dental Sciences, Kagoshima University, 8-35-1 Sakuragaoka, Kagoshima, Japan;

    Department of Immunology, Graduate School and Faculty of Medicine, University of the Ryukyus, Uehara 207, Nishihara-cho, Okinawa, Japan;

    Department of Neurology and Geriatrics, Graduate School of Medical and Dental Sciences, Kagoshima University, 8-35-1 Sakuragaoka, Kagoshima, Japan;

    Division of Molecular Pathology, Center for Chronic Viral Diseases;

  • 收录信息
  • 原文格式 PDF
  • 正文语种
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号